In this presentation from the "Evolving Armamentarium for IBD: Is Our Target Within Reach?" symposium held in Chicago on May 8th, 2017, Dr. Gil Y. Melmed discusses the mechanisms of action of novel targeted therapeutics for the treatment of inflammatory bowel disease (IBD).
Earn CME Credit for a related activity: [ Ссылка ]
© 2017 Imedex, LLC.
